Transcatheter Arterial Embolization Research Articles

Super‐stable homogeneous embolic agents advance the treatment of hepatocellular carcinoma

Super‐stable homogeneous embolic agents advance the treatment of hepatocellular carcinoma

Use of preoperative contrast-enhanced computed tomography in damage control strategy for blunt liver injury: A case report

For patients with unstable abdominal trauma unresponsive to initial transfusion, the damage control strategy includes prompt hemostasis by open surgery and packing. Recently, a hybrid treatment that combines packing and transcatheter arterial embolization as a damage control strategy was reported to be effective; however, the indications and techniques are yet to be established. A 25-year-old male patient who was in shock due to severe liver injury after a traffic accident was brought to our emergency room by emergency services. After initial resuscitation, including resuscitative endovascular balloon occlusion of the aorta and blood transfusion, preoperative contrast-enhanced computed tomography indicated grade IV liver injury with active bleeding from the right hepatic artery. Damage control strategy with packing and subsequent transcatheter arterial embolization was determined to be useful. During treatment, bile leakage was observed. An endoscopic nasobiliary drainage tube was inserted, and the patient was treated conservatively. He was discharged on day 83 of hospitalization. Although using preoperative contrast-enhanced computed tomography before damage control surgery remains controversial, it can provide useful information to determine damage control strategy, including morphological evaluation of the injured area and the presence of active bleeding.

Two-in-One Visual Gelatin Embolization Microspheres for Precise Localization and Rapid Embolization Studies

Transcatheter arterial embolization (TAE) has played a huge role in interventional therapy and tumor embolization of organ hemorrhage and accidental hemorrhage. The selection of embolic materials with better biocompatibility is an important part of TAE. In this work, we prepared a gelatin microspheres (GMs) embolization material that simultaneously encapsulates silver sulfide quantum dots (Ag2S QDs) and barium sulfate (BaSO4), giving it good near-infrared second region (NIR-II) imaging and X-ray imaging effects, while luminescence effect of NIR-II is better than that of X-ray, which breaks the limitation of traditional embolization microspheres with only X-ray imaging. In order to improve the therapeutic effect on tumors, we loaded doxorubicin (DOX) antitumor drugs inside the microspheres and bound thrombin on the surface of the microspheres. Thereby, not only can it help achieve rapid embolization during hemostasis, but its sustained release can also accelerate tumor necrosis. The microspheres have good biocompatibility and blood compatibility. Preliminary application results show that the microspheres can achieve a good embolization effect in the ear artery and renal artery of New Zealand white rabbits. Thus, they can be used as a potential embolization system for drug delivery as well as an effective material for arterial embolization and hemostasis. Significantly, this work realizes the clinical embolization application of NIR-II combined with X-ray multimodal imaging technology in biomedical imaging.

Serum lactate dehydrogenase concentration after transcatheter renal artery embolization correlates with reduction in renal angiomyolipoma volume.

The extent of renal angiomyolipoma (AML) volume reduction after renal transcatheter arterial embolization (TAE) varies between patients, with no predictive measure available. To determine whether the serum lactate dehydrogenase (LDH) concentration shortly after TAE correlates with the extent of tumor shrinkage. In a cohort of 36 patients undergoing prophylactic renal TAE for unruptured renal AML, we retrospectively acquired data from patient medical records, including serum LDH before and within 7 days after TAE and the tumor volume before and 12-36 months after TAE. The relationship between the serum level of LDH and reduction in tumor volume was evaluated using Spearman correlation analysis. The median LDH concentration was significantly higher after TAE than before (909.0 U/L vs. 186.5 U/L). This early post-TAE serum LDH level and LDH index (post-TAE LDH / pre-TAE LDH) correlated significantly and positively with the absolute decrease in tumor volume (both P < 0.0001). We observed no significant correlation between the relative tumor volume reduction and serum LDH level or LDH index. Serum LDH elevation occurs shortly after TAE and correlates with the extent of absolute decrease in AML volume at 12-36 months after TAE. Further large-scale studies are warranted to confirm the predictive role of post-TAE serum LDH level and LDH index in tumor shrinkage in patients with unruptured renal AML.

Usefulness of transcatheter arterial embolization for eighty-three patients with secondary postpartum hemorrhage: Focusing on difference in angiographic findings.

Transcatheter arterial embolization (TAE) has been widely used as an effective and a safe treatment method and was often used as an alternative to the surgical management, but there are limited studies on the efficacy and the safety for patients undergoing their secondary postpartum hemorrhage (PPH). To evaluate the usefulness of TAE for secondary PPH focusing on the angiographic findings. We conducted a research from January 2008 to July 2022 on all 83 patients (mean: 32 years, range: 24-43 years) presented with secondary PPH and they were treated with TAE in two university hospitals. The medical records and angiography were retrospective reviewed in order to evaluate the patients' characteristics, delivery details, clinical status and peri-embolization management, angiography and embolization details, technical/clinical success and complications. The group with active bleeding sign and the group without it were also compared and analyzed. On angiography, 46 (55.4%) patients showed active bleeding signs such as contrast extravasation (n = 37) or pseudoaneurysm (n = 8) or both (n = 1), and 37 (44.6%) patients showed non-active bleeding signs such as only spastic uterine artery (n = 2) or hyperemia (n = 35). In the active bleeding sign group there were more multiparous patients, low platelet count, prothrombin time prolongation, and high transfusion requirements. The technical success rates were 97.8% (45/46) in active bleeding sign group and 91.9% (34/37) in non-active bleeding sign group, and the overall clinical success rates were 95.7% (44/46) and 97.3% (36/37). An uterine rupture with peritonitis and abscess formation occurred to one patient after the embolization, therefore hysterostomy and retained placenta removal were performed which was a major complication. TAE is an effective and a safe treatment method for controlling secondary PPH regardless of angiographic findings.

Therapeutic response and prognostic factors of 14 dogs undergoing transcatheter arterial embolization for hepatocellular masses: A retrospective study.

Information regarding the therapeutic effect and outcome of transcatheter arterial embolization (TAE) for hepatic masses is limited in veterinary medicine. To analyze the therapeutic response, outcome (overall survival), and their predictors in dogs that underwent TAE for primary hepatocellular masses. We hypothesized that larger pre-TAE tumors would be associated with worse outcomes. Fourteen client-owned dogs. Retrospective study. Medical records between 1 September 2016 and 30 April 2022 were reviewed to identify dogs treated with TAE for hepatic masses diagnosed as hepatocellular origin by cytological or histopathological examination. Computed tomography images were compared before and after TAE. The univariate Cox proportional hazards test was performed to assess the associations between variables and survival. Univariate linear regression analysis was performed to assess the associations between variables and the tumor reduction percentage: ([post-TAE volume - pre-TAE volume]/pre-TAE volume) × 100. The median survival time was 419 days (95% confidence interval, 82-474). History of intra-abdominal hemorrhage (P = .03) and pre-TAE tumor volume/body weight (P = .009) were significantly associated with overall survival. The mean reduction percentage was -51% ± 40%. Pre-TAE tumor volume/body weight ratio (cm3 /kg; P = .02, correlation coefficient = 0.704) was significantly correlated with the volume reduction percentage. History of intra-abdominal hemorrhage and large pre-TAE tumor volume/body weight ratio could be predictive factors for adverse outcomes after TAE. Pre-TAE tumor volume/body weight ratio could be a predictive factor for therapeutic effect.

Preoperative Arterial Embolization of Musculoskeletal Tumors: A Tertiary Center Experience.

The purpose of this study was to report the effectiveness of preoperative transcatheter arterial embolization (TAE) of musculoskeletal tumors in terms of blood loss and functional outcomes. Patients who underwent preoperative TAE of hypervascular musculoskeletal tumors between January 2018 and December 2021 were retrospectively included. The patients' characteristics, TAE procedure details, degree of post-TAE devascularization, surgical outcomes in terms of red blood cell transfusion and functional results were collected. The degree of devascularization was compared between patients who had peri-operative transfusion and those who did not. Thirty-one patients were included. The 31 TAE procedures led to complete (58%) or near-complete (42%) tumor devascularization. Twenty-two patients (71%) had no blood transfusion during surgery. Nine patients (29%) had a blood transfusion, with a median number of red blood cell packs of three (q1, 2; q3, 4; range: 1-4). Eight patients (27%) had complete improvement of the initial musculoskeletal symptoms at the end of the follow-up, 15 (50%) had partially satisfying improvement, 4 (13%) had partially unsatisfying improvement and 3 (10%) had no improvement. Our study suggests that preoperative TAE of hypervascular musculoskeletal tumors allowed for bloodless surgery in 71% of patients and minimal transfusion needs for the remaining 29%.

Kidney Transplantation After Renal Transcatheter Arterial Embolization for Cyst Infection in a Hemodialysis Patient With Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 31-year-old woman with autosomal dominant polycystic kidney disease (ADPKD) required antibiotic therapy for repeated renal cyst infections. The patient was scheduled for a living donor renal transplant with her mother as the donor. Two months before surgery, the patient was admitted to the hospital due to a severe renal cyst infection that improved with antibiotic treatment and percutaneous drainage, but the scheduled surgery was postponed. Transcatheter arterial embolization (TAE) was performed to control repeated renal cyst infections. Seven months after TAE, the patient underwent living donor renal transplantation. The postoperative course was uneventful, and the patient was discharged from the hospital on immunosuppressive medication 26 days after surgery with no evidence of recurrent infection or deterioration of renal function. Thirty months after transplantation, there has been no recurrence of infection.

血胸を伴う出血性ショックを来した左胃動脈瘤破裂の1例(A ruptured aneurysm of left gastric artery that progressed to right hemothorax: a case report)

症例は50歳代女性，心窩部痛と呼吸苦で発症し，近医にて胸水を指摘されて前医を受診した。前医では，単純CT検査で血性胸腹水，食道壁肥厚，膵周囲の脂肪織濃度の上昇を認め，2日間加療したが改善を認めないため精査目的に当院へ紹介された。来院時，四肢末梢に湿潤を認め，脈拍110/分，血圧80/50mmHg（ドパミン9μg/kg/min）であった。造影CT検査で右血性胸水と食道裂孔ヘルニア，胸部中部以下の食道から胃噴門部小弯側にかけての血腫を認めたが，食道や肺野など胸部には出血源を認めなかった。腹腔内には血性腹水とともに，胸部中部食道周囲から胃小彎側に連続する血腫を認め，内部に直径1.5cmの左胃動脈瘤を認めた。左胃動脈瘤破裂による出血が，食道裂孔を介して縦隔へ進展し，胸腔内に穿破して血胸に至ったものと推測した。血胸に対して単回の胸腔穿刺，左胃動脈瘤破裂に対して血管造影による塞栓術を施行した。翌日から経口摂取を開始し，血胸が再燃することもなく経過は良好で，第22病日に自宅退院した。腹部内臓動脈瘤破裂による出血が食道裂孔を介して胸腔内に穿破し，血胸を契機に診断された稀な症例を経験したので報告する。 A 59–year–old woman visited her local hospital with dyspnea and epigastric pain. A chest X–ray showed a right pleural effusion. The patient consulted a second hospital where she was treated for two days, but due to her unstable vital signs, she was transferred to our hospital. A contrast–enhanced CT scan revealed a right hemothorax and esophageal hiatal hernia. While there was no source of bleeding in the thoracic cavity, there was an intra–abdominal hemorrhage from a ruptured aneurysm of the left gastric artery. The suspected cause of the hemothorax was bleeding from a ruptured aneurysm that entered the thoracic cavity through the esophageal hiatus. We performed a transcatheter arterial embolization for the ruptured aneurysm. After treatment, the patient recovered without significant incidents and was discharged on the 22nd day of hospitalization. We speculated that the hemorrhage from the rupture of the gastric aneurysm extended through the esophageal hiatus into the mediastinum and perforated into the thoracic cavity, resulting in a hemothorax. Since such conditions are rare, we will report this case with a review of the literature. 腹部内臓動脈瘤は破裂すれば出血性ショックにより致死的状況に至ることもある重篤な疾患である。本邦の腹部内臓動脈瘤破裂として報告されている症例の多くは腹腔内出血による出血性ショックを呈している 1, 2。しかし，今回我々は左胃動脈瘤破裂による出血が食道裂孔ヘルニアを介して縦隔，胸腔内へ進展し，出血性ショックを来した症例を経験したので，文献的考察を加えて報告する。 本論文は，個人情報保護法に基づいて匿名化がなされており，本人から論文報告に関する同意を得ている。また，本論文は倫理委員会の承諾を要する事項として該当しない。 症 例：50歳代の女性 主 訴：心窩部痛 現病歴：搬送6日前に突然の心窩部痛，呼吸困難感が出現し，食事摂取ができなくなった。搬送2日前に近医を受診したところ，胸水を指摘され前医を紹介された。前医受診時より血圧が低下しており，単純CT検査で血性胸腹水，食道壁肥厚，膵周囲の脂肪織濃度の上昇を認め急性膵炎などが疑われた。2日間の入院加療後も改善に乏しく，循環動態の維持にカテコラミン投与を要する状態となったため，当院救命救急センターへ搬送された。 既往歴：特記事項なし 生活歴：ビール１本/日，喫煙なし 来院時現症：意識清明。軽度の呼吸困難感の訴えを認めるが呼吸促拍はなく，呼吸数22/分，酸素飽和度97%（3L/min），顔面蒼白，四肢末梢に冷感湿潤を認め，脈拍110/分，血圧80/50mmHg（ドパミン 9µg/kg/min）。左背部痛の訴えがあるものの圧痛は認めなかった。 血液検査：RBC 213×104 /μL，Hb 6.7g/dL（前医受診時 Hb 9.8g/dL）と著明な貧血を認めた。血小板数や凝固検査には異常を認めなかった。 画像検査：胸腹部造影CT検査；胸部CTでは右血胸，滑脱型食道裂孔ヘルニアを認め，周囲に縦隔血腫，左少量胸水を認めた。腹部CTでは直径1.5cmの左胃動脈瘤を認め（Fig. 1a），周囲の血腫は胸部中部食道周囲から胃小弯側へ連続していた（Fig. 1b）。左肝動脈は左胃動脈から分岐しており，肝左葉外側区に微小動脈瘤を認めた。食道や肺野には出血源を認めなかった。 An enhanced CT scan of the abdomen revealed a pseudoaneurysm of the left gastric artery. Computed tomography (CT) of the chest showed a right massive hemothorax，a slipped esophageal hiatal hernia, and a mediastinal fluid collection (black arrow). 搬入後経過：乳酸リンゲル液の急速輸液を行うとともに輸血を開始した。搬入後より呼吸困難感が増悪し，仰臥位の維持が困難となったため，右血胸に対し慎重に胸腔穿刺を施行したところ，約830mLの血性排液を認めた。穿刺後，呼吸困難感の改善を認め，輸血投与後よりバイタルサインの安定を得た。左胃動脈瘤からの出血が食道裂孔ヘルニアを介して血胸に進展したものと推測し，動脈瘤に対して緊急interventional radiology（IVR）による止血術を行う方針とした。 腹部血管造影：腹腔動脈からの造影では，直径1.5cmの左胃動脈瘤を認め（Fig. 2a），瘤よりも近位より分岐する左胃動脈分枝，瘤末梢から分岐する左肝動脈を金属コイルでisolationし，瘤内をNBCA（n–butyl–2–cyanoacrylate）により塞栓した（Fig. 2b）。 Celiac artery angiography showed a pseudoaneurysm of the left gastric artery and left hepatic artery. Transcatheter arterial embolization (TAE) was done successfully. Arterial flow for the aneurysm was shut out. 入院後経過：後日判明したmyeloperoxidase–anti–neutrophil cytoplasmic antibodies（MPO–ANCA）や，proteinase–3–anti–neutrophil cytoplasmic antibodies （PR3–ANCA）などの血管炎マーカーはいずれも陰性であり，微小動脈瘤形成の所見から，臨床的に節性動脈中膜壊死（segmental arterial mediolysis: SAM）と診断した。濃厚赤血球4単位の輸血投与と緊急IVR後は循環動態の安定が得られた。呼吸器症状も改善し第2病日から経口摂取を開始した。胸水の再貯留は認めず，その後も血胸が再燃することはなかった。IVR後大きな合併症なく経過は良好で，第22病日に独歩で退院した。その後発症から1年までの時点では，新たな動脈瘤の形成もなく経過している。 腹部内臓動脈瘤は比較的稀な疾患であり，その発生頻度は0.01～2%とされている。Stanleyらの腹部内臓動脈瘤1,118例の集計によると，脾動脈が最も多く656例（58.7%），次いで肝動脈が227例（20.2%），上腸間膜動脈瘤89例（7.9%）と続くのに対し，胃動脈瘤は53例（4.7%）であると報告されている 3。 腹部内臓動脈瘤の成因としては，動脈硬化，神経線維種症I型やEhlers–Danlos症候群などの先天性疾患，腹部外傷，ベーチェット病や高安病，多発血管炎などの膠原病，正中弓状靭帯圧迫症候群，慢性膵炎などの炎症性疾患などがあるが，近年画像診断の進歩に伴って，SAMが注目されている 4。SAMは1976年にSlavinらにより提唱された疾患概念 5で，腹部内臓動脈の中膜が分節性に融解し動脈瘤を呈する病態である。稲田らの報告によると，SAMと診断された患者の35.7%に多発動脈瘤を認めており，一般的には異所性，異時性に動脈瘤を形成することが多いとされている 6。 SAMの確定診断は切除標本からの病理学的診断によってなされていたが，近年，画像診断の進歩や開腹手術と比較して低侵襲であるIVRが動脈瘤治療の第一選択となってきており，病理学的確診が得られる機会が少なくなってきた。内山ら 7は腹部内臓動脈瘤の中で，①中高年の患者，②炎症性変化や動脈硬化性病変などの基礎疾患がない患者，③突然の腹腔内出血で発症，④血管造影で血管の数珠状の不正な拡張と狭小化を認める，の4項目をSAMの特徴とし，これに合致するものをSAMと診断する臨床的診断基準を提唱している。本症例においては，中年女性であること，非動脈硬化性，非炎症性であること，血管造影検査で左胃動脈だけでなく左肝動脈外側区領域にも動脈瘤を形成し，特徴的な数珠状変化も認めていたことから臨床的にSAMと診断した。 また，胃動脈瘤の中では左胃動脈瘤破裂が最も多く報告されている。医学中央雑誌による検索では，左胃動脈瘤破裂の本邦報告例は25例であり，いずれも腹腔内出血あるいは消化管出血によるショック症状で搬送されていた。海外においては，腹部内臓動脈瘤破裂に伴い胸水貯留を呈した症例についての報告 8, 9, 10が散見される。一般に，腹部内臓動脈瘤破裂は血性腹水の貯留を認めるが，本症例の場合は血胸を呈していた。横隔膜を隔てた液体成分の移動に関して，腹腔内圧の上昇に伴い，横隔膜小孔を通じて胸腔内へ液体成分が漏出した症例報告がみられる。本症例では，滑脱型食道裂孔ヘルニアが存在し，腹腔内における血腫が食道裂孔を介して腹腔から縦隔へ連続していた。食道裂孔は伸縮性を持つ約3cmの筋性管で，左右の横隔膜脚内側縁により境界される。食道裂孔を形成する筋束は右脚の内側部から送られ，これが食道を包むようにめぐっており，下部食道～胃噴門部は横隔食道膜という靭帯に固定されている。食道裂孔ヘルニアとは，加齢によりこの横隔食道膜が弛緩することにより胃の一部が胸腔側に逸脱した状態である。食道は漿膜を持たず，周囲は疎な結合組織と脂肪組織に覆われているため，食道胃接合部手術における剥離は容易である。また，右胸腔とは薄い食道臓器鞘で接していることから，剥離操作時には右胸腔開放に注意を要する。腹部内臓動脈瘤破裂症例で，合併する食道裂孔ヘルニアを通じて胸腔穿破，胸水貯留を来した報告は少数にみられ 11, 12，食道裂孔ヘルニア内の胃穿孔から縦隔気腫や膿瘍を形成した報告例 13もある。また，慢性膵炎における仮性膵嚢胞で，嚢胞が後腹膜を頭側へ進展することで食道裂孔を貫き，胸腔へ穿破，内瘻を形成したことで膵性胸水貯留を来した症例も報告されている 14。食道裂孔部が弛緩した状態では，食道周囲の結合組織が疎であることによる血腫の下縦隔への進展，そこに接する胸膜穿破が起こりうると考える。本症例は，画像診断では血胸の原因となる病変を肺，胸膜，食道に認めず，単回の胸腔穿刺ドレナージとIVRによる止血術で血胸の再燃を認めなかった。左胃動脈瘤破裂による出血が，腹腔内の圧が上昇したことで，最も抵抗の少ない食道裂孔ヘルニア部から疎な結合組織を通じて縦隔へ進展し，壁側胸膜を穿破して血胸に至ったものと推測した。 右血胸を伴い出血性ショックを呈した左胃動脈瘤破裂の症例を経験した。腹腔内を出血源とする血液が，食道裂孔ヘルニアを介して主に胸腔内へと進展した可能性が考えられた。 共著者全員が利益相反はない。

Usefulness of indocyanine green fluorescence-guided small intestinal bleeding site identification in small bowel resection: a report of two cases and literature review.

Small bowel bleeding that does not respond to conservative therapy requires surgical resection. However, identifying the bleeding sites intraoperatively is challenging. Indocyanine green (ICG) fluorescence imaging improves diagnosis of small bowel bleeding and surgical decision-making by visualizing blood flow. Herein, we reported two cases of small bowel bleeding that were successfully treated by using ICG to identify the bleeding sites and determine the extent of small bowel resection. The patients were a 46-year-old and a 75-year-old woman, both of whom presented with melena. Contrast-enhanced computed tomography and arteriography confirmed small bowel bleeding, and rebleeding occurred in both patients after transcatheter arterial embolization. Emergent surgeries were performed, and intraoperative selective angiography with ICG injections was conducted to identify obscure bleeding sites. ICG fluorescence identified all bleeding sites in both cases, and small bowel resections were successfully performed. The postoperative courses were uneventful, and both patients had a favorable postoperative course without recurrence of bleeding. ICG fluorescence imaging can safely identify the sites of intestinal bleeding and determine the appropriate extent of bowel resection.

Transcatheter arterial embolization of cystic artery bleeding.

The purpose of this study is to assess the safety and clinical outcomes of transcatheter arterial embolization (TAE) via the cystic artery for treating patients with bleeding from the cystic artery. This retrospective study included 20 patients who underwent TAE via the cystic artery between January 2010 and May 2022. Radiological images and clinical data were reviewed to evaluate causes of bleeding, procedure-related complications, and clinical outcomes. Technical success was defined as the disappearance of contrast media extravasation or pseudoaneurysm, as demonstrated on completion angiography. Clinical success was defined as discharge from the hospital without any bleeding-related issues. Hemorrhagic cholecystitis (n = 10) was the most common cause of bleeding, followed by iatrogenic (n = 4), duodenal ulcer (n = 3), tumor (n = 2), and trauma (n = 1). Technical success was achieved in all cases, and clinical success was achieved in 70% (n = 14) of patients. Three patients developed ischemic cholecystitis as a complication. Six patients with clinical failure died within 45 days after embolization. TAE through the cystic artery has a high technical success rate in treating cystic artery bleeding, but clinical failure remains a common occurrence due to concurrent medical conditions and the development of ischemic cholecystitis.

A case of refractory bleeding from duodenal angioectasia with acquired hemophilia A.

Acquired hemophilia A (AHA) is a coagulation disorder related to the factor VIII inhibitors, which might cause intractable bleeding of gastrointestinal tracts. However, its scarcity makes it difficult to recognize AHA as a pitfall of endoscopic hemostasis failure. An 81-year-old female with a history of endoscopic treatment for colon polyps visited a local hospital with chief compliments of bloody stool and severe anemia. During several examinations for the bleeding origin, esophagogastroduodenoscopy depicted a 5mm-sized hemorrhagic angioectasia of the duodenum, followed by treatment with argon plasma coagulation. However, hemostasis was not achieved by multiple sessions of endoscopic hemostasis and transcatheter arterial embolization, so blood transfusion was repeatedly done and she was transferred to our hospital. Laboratory data showed severe anemia with coagulation disorder. Based on the results of von Willebrand factor activity, factor VIII activity and factor VIII inhibitor, we diagnosed AHA as a comorbidity. Endoscopic hemostasis was confirmed only after improvement of APTT level and negative for the factor VIII inhibitor by hemostatic bypass treatment with recombinant active factor VII and immunosuppressive therapy with prednisolone and cyclophosphamide. In case of refractory bleeding of gastrointestinal tract, we should suspect of a comorbidity of coagulation disorder like AHA.

Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study

PurposeTo retrospectively evaluate cryoablation combined with prior transcatheter arterial embolization (TAE) for renal cell carcinoma (RCC) in non-dialysis patients with stage 4 or 5 chronic kidney disease (CKD).Materials and methodsPatients with stage 4 or 5 CKD undergoing TAE and cryoablation for RCC between May 2012 and October 2021 were included. TAE was selectively performed using iodized oil with absolute ethanol or gelatin sponge 1–14 days before cryoablation. Local efficacy, safety, and changes in renal function were evaluated.ResultsNine patients (seven men and two women; median age, 64 years; range 52–88 years) with nine RCCs (mean diameter, 3.0 ± 1.0 cm; range 1.7–4.7 cm) were included. The mean pre-treatment estimated glomerular filtration rate (eGFR) was 24.2 ± 5.6 ml/min/1.73 m2 (range 10.4–29.2 ml/min/1.73 m2). The mean amount of contrast medium used in TAE was 58 ± 29 ml (range 40–128 ml). Except in one patient (grade 3 pyelonephritis), no grade ≥ 3 complications occurred. During the follow-up period (median, 18 months; range 7–54 months), no local tumor progression occurred. In two patients with pre-treatment eGFR of < 20 ml/min/1.73 m2, hemodialysis was initiated at 3 and 19 months after cryoablation. At their last follow-up, the remaining seven patients showed a decrease of 6.2 ± 5.3 ml/min/1.73 m2 (range 0.7–17.2 ml/min/1.73 m2) in their eGFR.ConclusionCryoablation combined with TAE for RCC in non-dialysis patients with stage 4 or 5 CKD was effective and safe, with an acceptable impact on renal function.

Experimental study of the effects of absorbable gelatin sponge and non‑absorbable polyvinyl alcohol particle material used in transcatheter arterial embolization on liver tissues.

Hepatic trauma is a leading cause of death in major abdominal trauma, and transcatheter arterial embolization has been widely used to treat it. However, there is limited research on whether absorbable gelatin sponge (AGS) and non-absorbable polyvinyl alcohol particles (PVA) have different effects on liver tissue, making it an important area of exploration. The present study investigated this issue using animal experiments by performing transhepatic arterial embolization with AGS and PVA. The effects on normal liver tissue in rabbits were examined by detecting liver function and inflammatory indexes, conducting histopathological examination, and using western blotting to detect apoptotic proteins. There were significant differences between the AGS and PVA groups after embolization. The AGS group exhibited a trend of improvement at ~1 week after embolization, and all indicators were statistically different until day 21 compared with the PVA group. The AGS group exhibited improved repair of hepatocytes and the biliary system based on H&E staining, while the PVA group exhibited more severe necrosis of the hepatocytes and biliary system around the embolization site. The western blotting results indicated that the Bcl-2/Bax ratio decreased on day 1 and day 3, and then rebounded in the AGS group on days 7 and 21, demonstrating gradual repair of hepatocytes compared with the PVA group.

Recent Progress in Advanced Hydrogel-Based Embolic Agents: From Rational Design Strategies to Improved Endovascular Embolization.

Transcatheter arterial embolization, a minimally invasive treatment to deliberately occlude the blood vessels, has become a safe and effective procedure for the management of vascular diseases and benign/malignant tumors. Particularly, hydrogel-based embolic agents have garnered much attention because of their potential to address some of the limitations of clinically used embolic agents and can be rationally designed to impart more favorable characteristics or functions. In this review, the recent progress toward the development of polymer-based hydrogels for effective endovascular embolization, including the in situ gelling hydrogels mediated by physically or chemically crosslinking, imageable hydrogels for intraprocedural and postprocedural feedback, use of hydrogels as the drug depot for local delivery of therapeutic drugs, hemostatic hydrogels inducing extrinsic or intrinsic coagulation of blood, stimuli-responsive shape memory hydrogels as the smart embolization devices, and hydrogels incorporating external-stimuli functional materials for multidisciplinary therapy, is systemically summarized. Moreover, the potential considerations of hydrogel-based embolic agents confronted in therapeutic embolization are pointed out. Finally, the perspectives for the development of more effective embolic hydrogels are also highlighted.

X-RAY endovacular embolization in the treatment of ulcerate gastroduodenal bleeding

The use of targeted arterial embolization in the treatment of bleeding ulcers was accompanied by technical success in 97.6% of cases, clinical success in 95% of cases, bleeding recurrence occurred in 5% of patients, while repeated arterial embolization was used to eliminate it in 2.5% of cases. Delayed operations were performed in 8.3% of patients, mortality was 6.5%, which allows us to recommend transcatheter arterial embolization for the treatment of patients with ulcerative gastroduodenal bleeding.

Genicular artery embolization for early-stage knee osteoarthritis: results from a triple-blind single-centre randomized controlled trial

This study investigated the effects of transcatheter arterial embolization (TAE) on pain, function, and quality of life in people with early-stage symptomatic knee osteoarthritis (OA) compared to a sham procedure. A total of 59 participants with symptomatic Kellgren-Lawrence grade 2 knee OA were randomly allocated to TAE or a sham procedure. The intervention group underwent TAE of one or more genicular arteries. The control group received a blinded sham procedure. The primary outcome was knee pain at 12 months according to the Knee injury and Osteoarthritis Outcome Score (KOOS) pain scale. Secondary outcomes included self-reported function and quality of life (KOOS, EuroQol five-dimension five-level questionnaire (EQ-5D-5L)), self-reported Global Change, six-minute walk test, 30-second chair stand test, and adverse events. Subgroup analyses compared participants who received complete embolization of all genicular arteries (as distinct from embolization of some arteries) (n = 17) with the control group (n = 29) for KOOS and Global Change scores at 12 months. Continuous variables were analyzed with quantile regression, adjusting for baseline scores. Dichotomized variables were analyzed with chi-squared tests. Overall, 58 participants provided questionnaire data at 12 months. No significant differences were found for the primary and secondary outcomes, with both groups improving following the procedure. At 12 months, KOOS pain scores improved by 41.3% and 29.4% in the intervention and control groups, respectively. No adverse events occurred. Subgroup analysis indicated that the complete embolization group had significantly better KOOS Sports and Recreation, KOOS Quality of Life, and Global Change scores than the control group; 76.5% of participants who received complete embolization reporting being moderately or much better compared to 37.9% of the control group. TAE might produce benefits above placebo, but only when complete embolization of all genicular arteries is performed. Further comparative studies are required before definitive conclusions regarding the effectiveness of TAE can be made. Level of evidence: I.

Clinical Efficacy of Transcatheter Arterial Embolization for Acute Non-Variceal Gastrointestinal Bleeding

See the article "Clinical Outcomes of Transcatheter Arterial Embolization after Failed Endoscopic Intervention for Acute Non-Variceal Bleeding Associated with Benign Upper Gastrointestinal Diseases" on page 52.

Clinical Outcomes of Transcatheter Arterial Embolization after Failed Endoscopic Intervention for Acute Non-Variceal Bleeding Associated with Benign Upper Gastrointestinal Diseases

Background/Aims: Transcatheter arterial embolization (TAE) is useful for management of uncontrolled upper gastrointestinal (UGI) bleeding. We investigated clinical outcomes of TAE for non-variceal bleeding from benign UGI diseases uncontrolled with endoscopic intervention.Methods: This retrospective study performed between 2017 and 2021 across four South Korean hospitals. Ninety-two patients (72 men, 20 women) who underwent angiography were included after the failure of endoscopic intervention for benign UGI disease- induced acute non-variceal bleeding. We investigated the factors associated with endoscopic hemostasis failure, the technical success rate of TAE, and post-TAE 30-day rebleeding and mortality rates.Results: The stomach (52/92, 56.5%) and duodenum (40/92, 43.5%) were the most common sites of bleeding. Failure of endoscopic procedures was attributable to peptic ulcer disease (81/92, 88.0%), followed by pseudo-aneurysm (5/92, 5.4%), and angiodysplasia (2/92, 2.2%). Massive bleeding that interfered with optimal visualization of the endoscopic field was the most common indication for TAE both in the stomach (22/52, 42.3%) and duodenum (14/40, 35.0%). Targeted TAE, empirical TAE, and exclusive arteriography were performed in 77 (83.7%), nine (9.8%), and six patients (6.5%), respectively. The technical success rate, the post-TAE 30-day rebleeding rate, and the overall mortality rate were 100%, 22.1%, and 5.8%, respectively. On multivariate analysis, coagulopathy (OR, 5.66; 95% CI, 1.71~18.74; &lt;i&gt;P&lt;/i&gt;=0.005) and empirical embolization (OR, 5.71; 95% CI, 1.14~28.65; &lt;i&gt;P&lt;/i&gt;=0.034) were independent risk factors for post-TAE 30-day rebleeding episodes.Conclusions: TAE may be useful for acute non-variceal UGI bleeding. Targeted embolization and correction of coagulopathy can improve clinical outcomes.

Transarterial arterial sclerosing embolization for the treatment of propranolol-resistant subglottic hemangioma: Feasibility and effificacy.

To assess the effectiveness and safety of transcatheter arterial sclerosing embolization (TASE) for the treatment of subglottic hemangiomas that did not respond appreciably to propranolol. This study was a retrospective analysis. Of the 101 patients with subglottic hemangiomas admitted to our center, 10 (4 male and 6 female) patients were included in this study. All these patients underwent arterial embolization using Pingyangmycin and polyvinyl alcohol particles (300-500 μm). All patients were examined 1 month after the last treatment and monthly thereafter. TASE treatment was technically successful in all patients. Ten lesions were located in the subglottic region. The blood supply included the superior thyroid artery, brachiocephalic trunk, facial artery, and ascending pharyngeal arteries. The median maximal diameter of the hemangiomas significantly decreased from 8.5mm before treatment to 2mm after TASE (P <.05). The degree of laryngeal obstruction improved in all patients. No serious complications were noted. One patient developed fever postoperatively, and three patients had a mild cough. For even subglottic hemangiomas with suboptimal efficacy of propranolol, TASE significantly reduced the size of hemangiomas with minimal adverse effects. It had a positive effect on the improvement of airway stenosis caused by subglottic hemangioma with poor effect of oral propranolol.